○Keiko Ishino^1,5, Yuko Udaka^2,5, Mariko Iwase^2,5, Hideto Oyamada^2,5, Ishikawa Fumihiro^3,5, Daisuke Tanaka⁴, Yuji Kiuchi^2,5 (1. Division of Infection Control Sciences, Department of Clinical Pharmacy, Showa University School of Pharmacy, 2. Department of Pharmacology, Showa University School of Medicin, 3. Centre for Biotechnology, Showa University, 4. Health care center, Showa University, 5. PCR Centre for COVID-19, Showa University Hospital)

○Yuichiro Yamamoto¹, Mana Murae^1,2, Yoshimi Shimizu^2,3, Asuka Kobayashi¹, Masumi Houri¹, Tetsuya Inoue¹, Takuya Irie^1,2, Ryutaro Gemba^2,4, Akiyoshi Saitoh¹, Satoru Miyazaki¹, Isao Ishii⁵, Masayoshi Fukasawa^1,2, Kohji Noguchi^1,2 (1. Facul. Pharm. Sci., Tokyo Univ. Sci., 2. Natl. Inst. Infect. Dis., 3. Facul. Pharm. Sci., Teikyo Heisei Univ., 4. Facult. Science. Div., Tokyo Univ. Sci., 5. Facul. Pharm. Sci., Showa Pharm. Univ.)

○Sayaka Deguchi¹, Kaori Kosugi¹, Rina Hashimoto¹, Ryosuke Negoro², Takuya Yamamoto^1,3,4, Takeshi Noda⁵, Miki Nagao⁶, Yu-suke Torisawa⁷, Kazuo Takayama^1,3 (1. CiRA, Kyoto Univ., 2. Col. of Pharm. Sci., Ritsumeikan Univ., 3. AMED-CREST, 4. WPI-ASHBi, Kyoto Univ., 5. Inst. for Frontier Life and Med. Sci., Kyoto Univ., 6. Grad. Sch. of Med., Kyoto Univ., 7. Grad. Sch. of Eng., Kyoto Univ.)

○Takeshi Morita¹, Kei Miyakawa¹, Tomoko Kuniyoshi², Jinwei Yang², Akihide Ryo¹ (1. Grad. Sch. Medic. Sci., Microbiology, Yokohama City Univ., 2. TOKIWA Phytochemical Co., Ltd.)

○Itsuki Anzai¹, Junso Fujita^2,3, Chikako Ono^4,5, Yoichiro Kosaka⁶, Yuki Miyamoto⁶, Shintaro Shichinohe¹, Kosuke Takada¹, Tadahiro Kajita⁶, Tsuyoshi Inoue³, Keiichi Namba^2,7,8, Tokiko Watanabe^1,4, Yoshiharu Matsuura^4,5 (1. Dept. Mol. Virol., RIMD, Osaka Univ., 2. Grad. Sch. Front. Biosci., Osaka Univ., 3. Grad. Sch. Pharm. Sci., Osaka Univ., 4. CiDER, Osaka Univ., 5. Lab. of Virus Control, RIMD, Osaka Univ., 6. BMR Inc., 7. JEOL YOKOGUSHI Research Alliance Lab., Osaka Univ., 8. BDR, RIKEN)